1. Germany Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Merck KGaA

Merck KGaA

MKKGY
Merck KGaAUS flagOther OTC
31.51
USD
-0.59
- -
68.50BMarket Cap

Total Valuation

Merck KGaA carries a market capitalization of 68.50B, placing it among publicly traded companies globally. Its enterprise value stands at 12.76B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap68.50B
Enterprise Value12.76B

Share Statistics

Merck KGaA currently has 434.78M shares outstanding.

Shares Outstanding434.78M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Merck KGaA trades at a trailing price-to-earnings ratio of 33.99.

PE Ratio33.99
PS Ratio4.07
PB RatioN/A
P/TBV RatioN/A
P/FCF Ratio12.38
P/OCF Ratio17.62

Enterprise Valuation

On an enterprise value basis, Merck KGaA trades at an EV/EBITDA multiple of 4.72 and an EV/FCF ratio of 2.35. The EV/Sales ratio of 0.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.72 provides insight into valuation relative to core operating earnings.

EV / Sales0.81
EV / EBITDA4.72
EV / EBIT4.72
EV / FCF2.35

Financial Position

Merck KGaA maintains a current ratio of 4.47, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.81, indicating elevated leverage, while an interest coverage ratio of 8.11 demonstrates adequate ability to service its debt obligations.

Current Ratio4.47
Quick Ratio1.07
Debt / Equity123.81
Debt / EBITDAN/A
Interest Coverage8.11

Financial Efficiency

Merck KGaA posts a return on equity of 13.31 and a return on invested capital of 10.86.

Return on Equity (ROE)13.31
Return on Assets (ROA)7.94
Return on Invested Capital (ROIC)10.86
Return on Capital Employed (ROCE)11.31
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.89

Taxes

Over the trailing twelve months, Merck KGaA has paid 502.00M in income taxes, reflecting an effective tax rate of 20.99.

Income Tax502.00M
Effective Tax Rate20.99

Stock Price Statistics

Merck KGaA's stock has gained approximately 20.58936% over the past 52 weeks. The 50-day moving average sits at 32.41, while the 200-day moving average is 29.24.

Beta (5Y)N/A
52-Week Price Change20.58936%
50-Day Moving Average32.41
200-Day Moving Average29.24
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Merck KGaA generated 15.70B in revenue and converted that into 1.88B in net income, yielding earnings per share of 0.87. EBITDA reached 2.70B, while operating income came in at 2.70B.

Revenue15.70B
Gross Profit9.24B
Operating Income2.70B
Pretax Income2.39B
Net Income1.88B
EBITDA2.70B
EBIT2.70B
Earnings Per Share (EPS)0.87

Cash Flow

Merck KGaA produced 3.63B in operating cash flow over the past twelve months. After subtracting -1.53B in capital expenditures, free cash flow totaled 2.09B - equivalent to 0.96 per share.

Operating Cash Flow3.63B
Capital Expenditures-1.53B
Free Cash Flow2.09B
FCF Per Share0.96

Margins

Merck KGaA operates with a gross margin of 58.84, reflecting its pricing power and cost economics. The operating margin of 17.21 and net profit margin of 11.97 provide insight into operational efficiency.

Gross Margin58.84
Operating Margin17.21
Pretax Margin15.23
Profit Margin11.97
EBITDA Margin17.21

Dividends & Yields

The company's payout ratio of 0.74 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.01
Dividend YieldN/A
Payout Ratio0.74
Shareholder Yield-19.06
FCF Yield8.08

Stock Splits

Merck KGaA's most recent stock split took place on August 15, 2017 with a 500:833 split ratio.

Last Split Date8/15/2017
Split Ratio500:833

Scores

Merck KGaA posts an Altman Z-Score of 9.21, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score9.21